Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
PUT
Cal-Maine
CALM
$3.99B
| $3.58M | ﹤0.01% |
80,500
-22,000
| -21% | -$981K |
|
1902
ProPetro Holding
PUMP
$1.35B
| $3.58M | ﹤0.01% |
177,535
+168,536
| +1,873% | +$2.86M |
|
|
MRO
1903
PUT
DELISTED
Marathon Oil Corporation
MRO
| $3.58M | ﹤0.01% |
211,300
-74,200
| -26% | -$1.1M |
|
|
CMBT
1904
CMB.TECH NV
CMBT
$4.73B
| $3.57M | ﹤0.01% |
386,399
-123,022
| -24% | -$1.04M |
|
|
STOR
1905
DELISTED
STORE Capital Corporation
STOR
| $3.57M | ﹤0.01% |
137,154
-42,225
| -24% | -$1.08M |
|
|
SPLK
1906
PUT
DELISTED
Splunk Inc
SPLK
| $3.57M | ﹤0.01% |
43,100
-68,000
| -61% | -$4.99M |
|
1907
PUT
Microchip Technology
MCHP
$46B
| $3.57M | ﹤0.01% |
81,200
+39,200
| +93% | +$1.77M |
|
1908
HF Sinclair
DINO
$14.5B
| $3.56M | ﹤0.01% |
69,490
-130,148
| -65% | -$5.5M |
|
1909
CALL
Fluor
FLR
$7.96B
| $3.55M | ﹤0.01% |
68,800
+34,400
| +100% | +$1.6M |
|
1910
Chemed
CHE
$7.22B
| $3.54M | ﹤0.01% |
14,562
+12,393
| +571% | +$2.82M |
|
|
PE
1911
DELISTED
PARSLEY ENERGY INC
PE
| $3.53M | ﹤0.01% |
119,857
+68,730
| +134% | +$1.84M |
|
1912
CALL
Westlake Corp
WLK
$9.9B
| $3.53M | ﹤0.01% |
33,100
-3,600
| -10% | -$334K |
|
1913
CALL
Sanofi
SNY
$104B
| $3.52M | ﹤0.01% |
81,800
+100
| +0.1% | +$4.61K |
|
|
NVO
1914
Novo Nordisk
NVO
$209B
| $3.52M | ﹤0.01% |
130,972
-792
| -0.6% | -$20.1K |
|
1915
Natural Resource Partners
NRP
$1.42B
| $3.51M | ﹤0.01% |
135,000
| – | – |
|
1916
PUT
Tapestry
TPR
$32.8B
| $3.5M | ﹤0.01% |
79,200
+9,500
| +14% | +$392K |
|
|
SYNH
1917
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.49M | ﹤0.01% |
80,079
+39,423
| +97% | +$1.84M |
|
|
SABA
1918
Saba Capital Income & Opportunities Fund II
SABA
$223M
| $3.49M | ﹤0.01% |
270,084
| – | – |
|
1919
ProShares Ultra S&P500
SSO
$8.36B
| $3.48M | ﹤0.01% |
254,520
+73,664
| +41% | +$953K |
|
1920
NewMarket
NEU
$8.18B
| $3.48M | ﹤0.01% |
8,755
+1,391
| +19% | +$564K |
|
1921
PUT
Rockwell Automation
ROK
$49B
| $3.48M | ﹤0.01% |
17,700
+4,800
| +37% | +$915K |
|
|
WRI
1922
DELISTED
Weingarten Realty Investors
WRI
| $3.47M | ﹤0.01% |
105,606
+9,730
| +10% | +$315K |
|
|
VMW
1923
CALL
DELISTED
VMware, Inc
VMW
| $3.47M | ﹤0.01% |
27,700
-42,000
| -60% | -$5.04M |
|
|
MLNX
1924
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.47M | ﹤0.01% |
53,600
+41,500
| +343% | +$2.19M |
|
|
NVO
1925
PUT
Novo Nordisk
NVO
$209B
| $3.47M | ﹤0.01% |
129,200
+114,200
| +761% | +$2.9M |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.